0001895948-21-000002.txt : 20211202 0001895948-21-000002.hdr.sgml : 20211202 20211202152148 ACCESSION NUMBER: 0001895948-21-000002 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211201 FILED AS OF DATE: 20211202 DATE AS OF CHANGE: 20211202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Scripture Charity CENTRAL INDEX KEY: 0001895948 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36783 FILM NUMBER: 211466298 MAIL ADDRESS: STREET 1: C/O BELLICUM PHARMACEUTICALS, INC. STREET 2: 3730 KIRBY DRIVE, STE. 1200 CITY: HOUSTON STATE: TX ZIP: 77098 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC CENTRAL INDEX KEY: 0001358403 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 201450200 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 BUSINESS PHONE: (832) 384-1100 MAIL ADDRESS: STREET 1: 3730 KIRBY DRIVE STREET 2: SUITE 1200 CITY: HOUSTON STATE: TX ZIP: 77098 FORMER COMPANY: FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20060405 3 1 wf-form3_163847649646886.xml FORM 3 X0206 3 2021-12-01 0 0001358403 BELLICUM PHARMACEUTICALS, INC BLCM 0001895948 Scripture Charity C/O BELLICUM PHARMACEUTICALS, INC. 3730 KIRBY DRIVE, SUITE 1200 HOUSTON TX 77098 0 1 0 0 Chief Development Officer Common Stock 14587 D Stock Option (right to buy) 4.41 2028-11-01 Common Stock 2500.0 D Stock Option (right to buy) 1.36 2030-02-02 Common Stock 19300.0 D Stock Option (right to buy) 7.13 2030-08-02 Common Stock 20000.0 D Stock Option (right to buy) 2.97 2030-12-14 Common Stock 35000.0 D Stock Option (right to buy) 2.88 2031-08-16 Common Stock 50000.0 D 25% of the shares subject to the stock option vest and became exercisable on October 1, 2019, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter. 25% of the shares subject to the stock option vest and became exercisable on February 3, 2021, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter. 100% of the shares subject to the stock option vest and became exercisable on August 3, 2021. 50% of the shares subject to the stock option vest and become exercisable on December 15, 2021, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter. 50% of the shares subject to the stock option vest and become exercisable on August 16, 2022, and the remaining shares subject to the stock option vest and become exercisable in 12 equal monthly installments thereafter. Charity Scripture 2021-12-02